高级搜索

GDF11对肝细胞癌SMMC-7721细胞增殖能力及顺铂敏感度的影响

张菊萍, 史业辉, 贾勇圣, 周立艳, 佟仲生

张菊萍, 史业辉, 贾勇圣, 周立艳, 佟仲生. GDF11对肝细胞癌SMMC-7721细胞增殖能力及顺铂敏感度的影响[J]. 肿瘤防治研究, 2016, 43(6): 459-462. DOI: 10.3971/j.issn.1000-8578.2016.06.005
引用本文: 张菊萍, 史业辉, 贾勇圣, 周立艳, 佟仲生. GDF11对肝细胞癌SMMC-7721细胞增殖能力及顺铂敏感度的影响[J]. 肿瘤防治研究, 2016, 43(6): 459-462. DOI: 10.3971/j.issn.1000-8578.2016.06.005
ZHANG Juping, SHI Yehui, JIA Yongsheng, ZHOU Liyan, TONG Zhongsheng. GDF11 is Involved in Human Hepatic Carcinoma Cells SMMC-7721 Proliferation and Sensitivity to DDP[J]. Cancer Research on Prevention and Treatment, 2016, 43(6): 459-462. DOI: 10.3971/j.issn.1000-8578.2016.06.005
Citation: ZHANG Juping, SHI Yehui, JIA Yongsheng, ZHOU Liyan, TONG Zhongsheng. GDF11 is Involved in Human Hepatic Carcinoma Cells SMMC-7721 Proliferation and Sensitivity to DDP[J]. Cancer Research on Prevention and Treatment, 2016, 43(6): 459-462. DOI: 10.3971/j.issn.1000-8578.2016.06.005

GDF11对肝细胞癌SMMC-7721细胞增殖能力及顺铂敏感度的影响

详细信息
    作者简介:

    张菊萍(1987-),女,硕士在读,主要从事乳腺癌的综合治疗

    通讯作者:

    佟仲生,E-mail:tonghang@medmail.com.cn

  • 中图分类号: R735.7

GDF11 is Involved in Human Hepatic Carcinoma Cells SMMC-7721 Proliferation and Sensitivity to DDP

More Information
  • 摘要:
    目的 

    研究GDF11(growth differentiation factor 11)过表达对肝细胞癌SMMC-7721细胞体外增殖能力及顺铂敏感度的影响。

    方法 

    前期成功构建GDF11过表达的SMMC-7721细胞,同时以空载体感染细胞组及野生型细胞组为对照。CCK-8法检测细胞增殖能力,平板克隆形成实验检测细胞克隆形成能力。CCK-8法检测GDF11过表达对细胞顺铂药物敏感度的影响。

    结果 

    Western blot结果验证,已成功构建GDF11过表达的SMMC-7721细胞。GDF11过表达可明显抑制SMMC-7721细胞的体外增殖能力,在96、120及144 h时抑制作用最显著(P<0.05),且实验组细胞较对照组克隆形成能力明显减弱(P<0.05)。GDF11过表达能够增强肝细胞癌SMMC-7721细胞对顺铂的敏感度,顺铂浓度取20 μg/ml及40 μg/ml时,与对照组相比差异有统计学意义(P<0.05)。

    结论 

    肝细胞癌SMMC-7721细胞过表达GDF11蛋白后,其体外增殖及克隆形成能力明显降低,对化疗药物顺铂的敏感度增强。

     

    Abstract:
    Objective 

    To explore the influence of growth differentiation factor 11 (GDF11) overexpression on hepatic carcinoma cells SMMC-7721 proliferation ability and sensitivity to DDP in vitro.

    Methods 

    Previous study had successfully built SMMC-7721 cells with GDF11 over-expression. Meanwhile, empty vector infected cells and wild-type cells were treated as controls. Cells proliferation ability was examined by CCK-8 assay, and the proliferation curve was calculated. Colony formation assay was adopted to evaluate colony formation ability. The SMMC-7721 cells were treated with various concentrations of DDP, then the cell viability was measured using CCK-8 assay.

    Results 

    Western blot showed SMMC-7721 cells with GDF11 over-expression had successfully built. The overexpression of GDF11 could significantly inhibit the proliferation of SMMC-7721 cells in vitro, and the effect were significant at 96, 120, 144h (P<0.05) . Meanwhile GDF11 over-expression group had lower ability of colony formation than control groups(P<0.05) . The over-expression of GDF11 made SMMC-7721 cells more sensitive to DDP, and the effect were significant at 20 and 40μg/ml DDP (P<0.05) .

    Conclusion 

    The over-expression GDF11 could inhibit the proliferation and colony formation abilities of SMMC-7721 cells, and enhance its sensitivity to DDP.

     

  • 图  1   Western blot检测三种细胞中GDF11蛋白的表达水平

    Figure  1   Expression of GDF11 in GDF11-7721, GFP-7721 and WT-7721 cells examined by Western blot

    图  2   CCK-8法检测GDF11蛋白过表达对细胞增殖能力的影响

    Figure  2   Effect of GDF11 over-expression on cell proliferation ability examined by CCK-8 assay

    图  3   平板克隆形成实验检测GDF11蛋白过表达对细胞克隆形成能力的影响

    Figure  3   Effect of GDF11 over-expression on cells colony formation ability

    图  4   GDF11蛋白过表达增强SMMC-7721细胞对顺铂的敏感度

    Figure  4   GDF11 over-expression could increase sensitivity of SMMC-7721 cells to DDP

  • [1] EI-serag HB, Rudolph KL. Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7): 25 57-76.
    [1]

    EI-serag HB, Rudolph KL. Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7) : 2557-76.

    [2]

    Ng KK, Lo CM, Liu CL, et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplantt[J]. Arch Surg, 2008, 143(1) : 68-74.

    [2] Ng KK, Lo CM, Liu CL, et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplantt[J]. Arch Surg, 2008, 143(1): 68-74.
    [3]

    Kim do Y, Paik YH, Ahn SH, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection[J]. Oncology, 2007, 72 Suppl 1: 52-7.

    [3] Kim do Y, Paik YH, Ahn SH, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection[J]. Oncology, 2007, 72 Suppl 1: 52-7.
    [4]

    McPherron AC. Metabolic Functions of Myostatin and Gdf11[J]. Immunol Endocr Metab Agents Med Chem, 2010, 10(4) : 217-31.

    [4] McPherron AC. Metabolic Functions of Myostatin and Gdf11[J]. Immunol Endocr Metab Agents Med Chem, 2010, 10(4): 217-31.
    [5] Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184): 649-52.
    [5]

    Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184) : 649-52.

    [6] Shi Y, Liu JP. Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord[J]. J Neurosci, 2011, 31 (3): 883-93.
    [6]

    Shi Y, Liu JP. Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord[J]. J Neurosci, 2011, 31(3) : 883-93.

    [7]

    Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014, 344(6184) : 630-4.

    [7] Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014, 344(6184): 630-4.
    [8] Zhang Y, Shao J, Yang T, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPAR gamma[J]. Gene, 2015, 557(2): 209-14.
    [8]

    Zhang Y, Shao J, Yang T, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPAR gamma[J]. Gene, 2015, 557(2) : 209-14.

    [9]

    Zarzynska JM. Two faces of TGF-beta1 in breast cancer[J]. Mediators Inflamm, 2014, 2014: 141747.

    [9] Zarzynska JM. Two faces of TGF-beta1 in breast cancer[J]. Mediators Inflamm, 2014, 2014: 141747.
    [10]

    Heldin CH, Landström M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelialmesenchymal transition[J]. Curr Opin Cell Biol, 2009, 21(2) : 166-76.

    [10] Heldin CH, Landström M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelialmesenchymal transition[J]. Curr Opin Cell Biol, 2009, 21(2): 166-76.
    [11]

    Moses H, Barcellos-Hoff MH. TGF-β biology in mammary development and breast cancer[J]. Cold Spring Harb Perspect Biol, 2011, 3(1) : a003277.

    [11] Moses H, Barcellos-Hoff MH. TGF-β biology in mammary development and breast cancer[J]. Cold Spring Harb Perspect Biol, 2011, 3(1): a003277.
    [12]

    Massagué J. TGF-β in cancer[J]. Cell, 2008, 134(2) : 215-30.

    [12] Massagué J. TGF-β in cancer[J]. Cell, 2008, 134(2): 215-30.
    [13] Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor[J]. J Surg Res, 2015, 198(1): 50-6.
    [13]

    Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor[J]. J Surg Res, 2015, 198(1) : 50-6.

图(4)
计量
  • 文章访问数:  1144
  • HTML全文浏览量:  263
  • PDF下载量:  322
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-08-09
  • 修回日期:  2015-09-21
  • 网络出版日期:  2024-02-04
  • 刊出日期:  2016-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭